Amgen psoriasis drug tops J&J's Stelara in Phase III study

[riky]

Amgen psoriasis drug tops J&J's Stelara in Phase III study

(Reuters) - Amgen Inc said on Tuesday that its experimental psoriasis drug, brodalumab, met all the goals of a late-stage study, clearing the rough skin patches associated with the disease more thoroughly than Johnson & Johnson's Stelara and a placebo. Amgen is developing brodalumab under a multi-drug collaboration with AstraZeneca that involves splitting costs and eventual profits. After 12 weeks of treatment of 1,881 patients with moderate to severe plaque psoriasis, 36. ...

Source: You are not allowed to view links. Register or Login